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Silicone, which is considered biologically inert, has been
used in many different types of medical devices, including
tubing; breast, joint and penile implants; artificial heart
valves; and intraocular lenses, among others. After a
silicone implant is placed, a mild reaction to the foreign
body is generally observed, followed by encapsulation (1).
Case reports of women with silicone breast implants and
connective tissue disease (CTD), especially scleroderma,
began to appear in English-language medical literature in
the 1980s. Currently, it is widely believed that there is no
association between silicone breast implants and autoim-
mune disease (1). However, when a patient presents with
autoimmune symptoms after silicone breast implantation,
the question often arises again.
Although several authors have reported the appearance
of CTDs (e.g., scleroderma, Still’s disease, systemic lupus
erythematosus (SLE), Sjogren’s Syndrome and dermato-
myositis) after silicone breast implantation, several case-
control studies do not show such an association. However,
there are a few points that deserve attention. Silicone breast
implants act as a foreign body, and inflammatory responses
to silicone, such as granulomatous skin reactions to injected
silicone, synovitis around silicone prosthetic joints and
lymphadenopathy proximal to silicone prostheses, have
been observed (2,3). Microscopic evidence of silicone has
been observed far from the original site (e.g., in the liver),
suggesting that a small quantity of silicone particles
detaches and migrates through the lymphatic or circulatory
system to other organs (1,4–6). They may act as adjuvants
and start an inflammatory process in joints or activate the
immune system and stimulate the production of autoanti-
bodies (1,2).
The activation of the immune system has been demon-
strated by the presence of antibodies to silicone and the
presence of autoantibodies in the sera of patients with
silicone breast implants. Although several studies have
detected increased titers of anti-silicone antibodies, no
association with clinical findings has been observed (6-10).
Significantly more patients with silicone breast implants
present with positive anti-DNA, Sjogren syndrome antigen B
(anti-SSB/La) and anticollagen II (6-10). Antibodies and
symptoms were more evident in patients who had possessed
implants for a longer time period (10).
In conclusion, silicone breast implants may act as a
foreign body and elicit autoantibody production. However,
thus far, no clear link between the presence of autoanti-
bodies and symptoms has been observed.
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